Lobular Breast Cancer An All-Round Multidisciplinary Overview

Giovanni Corso, MD, PhD, is a senior researcher at the University of Milan and a breast surgeon at the European Institute of Oncology in Milan. He earned his MD cum laude from the University of Siena, specialized in general surgery with honors and completed his PhD with honors in Medicine and Molecular Oncology from the University of Porto. Corso is president of the European Cancer Prevention Organization and editor-in-chief of the European Journal of Cancer Prevention. He has authored over hundreds of scientific articles, edited two books , and leads several funded research projects. A recognized international speaker, he has presented at dozens of conferences and received the ASCO merit award.

Prof. Robson is a board-certified medical oncologist who specializes in the identification and management of individuals who have inherited an increased risk for cancer. He concentrates on helping men and women with cancer incorporate genetic information into their treatment plan. For those who are at increased risk, but have not been diagnosed, he works to develop a plan that will help them either prevent the development of cancer, or limit its impact if it occurs. Along the same lines, his research focus has studied the best ways to use genetic information to improve the outcomes of those with or at risk for hereditary cancers of all types. Consistent with the goals, he pursues in his clinical genetics work, his oncology practice is weighted toward the management of young women with breast cancer, especially hereditary breast cancer. As part of that practice, he participates in the development of new treatments, such as PARP inhibitors, which may be particularly useful for this group of women. Finally, he also maintains a separate practice where he coordinates screening for women with mutations in BRCA1 or BRCA2